The correlation between metastasis-free survival and overall survival in non-metastatic castration resistant prostate cancer patients from the Medical Data Vision claims database in Japan. (3rd October 2019)
- Record Type:
- Journal Article
- Title:
- The correlation between metastasis-free survival and overall survival in non-metastatic castration resistant prostate cancer patients from the Medical Data Vision claims database in Japan. (3rd October 2019)
- Main Title:
- The correlation between metastasis-free survival and overall survival in non-metastatic castration resistant prostate cancer patients from the Medical Data Vision claims database in Japan
- Authors:
- Mori, Asuka
Hashimoto, Kohei
Koroki, Yosuke
Wu, David Bin-Chia
Masumori, Naoya - Abstract:
- Abstract: Background and purpose: Several recent randomized controlled trials (RCTs) in non-metastatic castration resistant prostate cancer (nmCRPC) have demonstrated a significant improvement in metastasis-free survival (MFS); however, an improvement in overall survival (OS) is not reported yet. Since the surrogacy of MFS to OS has not been formally investigated in nmCRPC in Japan, this study evaluated the correlation between MFS and OS among a nmCRPC population in Japan. Methods: This is a retrospective longitudinal observational cohort study in patients with nmCRPC using the Japanese Medical Data Vision (MDV) database covering over 20 million patients. A total of 1236 patients with CRPC who had no prior medical history of cancer except prostate cancer and no distant metastasis, and who fulfilled PCWG2 criteria, were identified. Following the identification of nmCRPC, patients' medical records were investigated for subsequent events of metastasis and death. Results: The median follow-up time was 24 months. Median MFS was 28 months (95% CI: 24.0 to 33.0 months) and median OS could not be estimated (95% CI: not estimated). There was a statistically significant correlation between MFS and OS (Pearson's correlation coefficient = 0.62; 95% CI: 0.58–0.65; p < .0001, Spearman's correlation coefficient = 0.62; 95% CI: 0.58–0.65; p < .0001 and Kendall's τ statistic = 0.53; 95% CI: 0.49–0.56; p < .0001). Conclusions: The results of this study indicate a significant correlationAbstract: Background and purpose: Several recent randomized controlled trials (RCTs) in non-metastatic castration resistant prostate cancer (nmCRPC) have demonstrated a significant improvement in metastasis-free survival (MFS); however, an improvement in overall survival (OS) is not reported yet. Since the surrogacy of MFS to OS has not been formally investigated in nmCRPC in Japan, this study evaluated the correlation between MFS and OS among a nmCRPC population in Japan. Methods: This is a retrospective longitudinal observational cohort study in patients with nmCRPC using the Japanese Medical Data Vision (MDV) database covering over 20 million patients. A total of 1236 patients with CRPC who had no prior medical history of cancer except prostate cancer and no distant metastasis, and who fulfilled PCWG2 criteria, were identified. Following the identification of nmCRPC, patients' medical records were investigated for subsequent events of metastasis and death. Results: The median follow-up time was 24 months. Median MFS was 28 months (95% CI: 24.0 to 33.0 months) and median OS could not be estimated (95% CI: not estimated). There was a statistically significant correlation between MFS and OS (Pearson's correlation coefficient = 0.62; 95% CI: 0.58–0.65; p < .0001, Spearman's correlation coefficient = 0.62; 95% CI: 0.58–0.65; p < .0001 and Kendall's τ statistic = 0.53; 95% CI: 0.49–0.56; p < .0001). Conclusions: The results of this study indicate a significant correlation between MFS and OS. It may justify the usefulness of MFS as surrogate for OS in nmCRPC. … (more)
- Is Part Of:
- Current medical research and opinion. Volume 35:Number 10(2019)
- Journal:
- Current medical research and opinion
- Issue:
- Volume 35:Number 10(2019)
- Issue Display:
- Volume 35, Issue 10 (2019)
- Year:
- 2019
- Volume:
- 35
- Issue:
- 10
- Issue Sort Value:
- 2019-0035-0010-0000
- Page Start:
- 1745
- Page End:
- 1750
- Publication Date:
- 2019-10-03
- Subjects:
- Non-metastatic castration resistant prostate cancer -- metastasis-free survival -- overall survival -- correlation -- claims database study
Clinical medicine -- Periodicals
Therapeutics -- Periodicals
615.5 - Journal URLs:
- http://informahealthcare.com ↗
- DOI:
- 10.1080/03007995.2019.1619543 ↗
- Languages:
- English
- ISSNs:
- 0300-7995
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3500.301000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 12903.xml